Given that this ncRNA epigenetic circuitry governs CDH13 expression across cardiovascular and metabolic disorders and cancer, targeting these key ncRNA pathways offers a promising strategy to reestablish T-cadherin/CDH13 protective functions in disease. The gene discussed is CDH13; the disease is metabolic disease.